IS7879A - Ný efnasambönd - Google Patents

Ný efnasambönd

Info

Publication number: IS7879A
Authority: IS; Iceland
Prior art keywords: new compounds; compounds; new
Prior art date: 2002-11-22

Application number

IS7879A

Other languages

English (en)

Other versions

IS2659B (is

Inventor

Hasegawa Masaichi

Tang Jun

Sato Hideyuki

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-22

Filing date

2005-06-02

Publication date

2005-06-02

2005-06-02 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2005-06-02 Publication of IS7879A publication Critical patent/IS7879A/is

2010-08-15 Publication of IS2659B publication Critical patent/IS2659B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

IS7879A 2002-11-22 2005-06-02 Þíasólidín-4-ón til að hamla gegn Hyak3 próteinum IS2659B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US42838402P	2002-11-22	2002-11-22
PCT/US2003/037658 WO2004047760A2 (en)	2002-11-22	2003-11-18	Novel chemical compounds

Publications (2)

Publication Number	Publication Date
IS7879A true IS7879A (is)	2005-06-02
IS2659B IS2659B (is)	2010-08-15

Family

ID=32393394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7879A IS2659B (is)	2002-11-22	2005-06-02	Þíasólidín-4-ón til að hamla gegn Hyak3 próteinum

Country Status (30)

Country	Link
US (1)	US7767701B2 (is)
EP (1)	EP1567112B1 (is)
JP (1)	JP2006509765A (is)
KR (1)	KR20050085115A (is)
CN (1)	CN100579978C (is)
AP (1)	AP1967A (is)
AR (1)	AR045407A1 (is)
AT (1)	ATE411302T1 (is)
AU (1)	AU2003298693B2 (is)
BR (1)	BR0316502A (is)
CA (1)	CA2507256A1 (is)
CY (1)	CY1108655T1 (is)
DE (1)	DE60324178D1 (is)
DK (1)	DK1567112T3 (is)
EA (1)	EA008865B1 (is)
EC (1)	ECSP055808A (is)
ES (1)	ES2315566T3 (is)
IS (1)	IS2659B (is)
MA (1)	MA27701A1 (is)
MX (1)	MXPA05005406A (is)
MY (1)	MY140132A (is)
NO (1)	NO20052928L (is)
NZ (1)	NZ539873A (is)
OA (1)	OA12963A (is)
PL (1)	PL377564A1 (is)
PT (1)	PT1567112E (is)
SI (1)	SI1567112T1 (is)
TW (1)	TWI309648B (is)
UA (1)	UA80572C2 (is)
WO (1)	WO2004047760A2 (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR122016021801B8 (pt)	2002-01-22	2021-05-25	Warner Lambert Co	compostos 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas
DK1648889T3 (da) *	2003-07-11	2009-01-05	Warner Lambert Co	Isethionatsalt af en selektiv CDK4-inhibitor
EP1648452B1 (en) *	2003-07-28	2009-07-22	Merck Serono SA	2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors
RU2379299C2 (ru)	2003-11-21	2010-01-20	Актелион Фармасьютиклз Лтд	Производные 5-(бенз-(z)-илиден)тиазолидин-4-она и их применение в качестве иммуносупрессорных агентов
USRE43833E1 (en)	2003-11-21	2012-11-27	Actelion Pharmaceuticals Ltd.	Thiazolidin-4-one derivatives
US20070249599A1 (en) *	2004-02-25	2007-10-25	Duffy Kevin J	Novel Chemical Compounds
AR050253A1 (es)	2004-06-24	2006-10-11	Smithkline Beecham Corp	Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
ATE420086T1 (de) *	2004-07-01	2009-01-15	Hoffmann La Roche	Chinolinthiazolinone mit cdk-1 antiproliferativer wirkung
CA2571738A1 (en) *	2004-07-01	2006-01-12	F. Hoffmann-La Roche Ag	Thiazolinone unsubstituted quinolines
US7253285B2 (en) *	2004-09-17	2007-08-07	Hoffmann-La Roche Inc.	Thiazolinone 4-monosubstituted quinolines
US7241893B2 (en) *	2004-09-17	2007-07-10	Hoffman-La Roche Inc.	Thiazolinone 2-substituted quinolines
MX2007004302A (es) *	2004-10-12	2007-06-07	Applied Research Systems	Inhibidores de pi3 cinasa gamma para el tratamiento de anemia.
RU2405781C2 (ru) *	2004-10-14	2010-12-10	Ф.Хоффманн-Ля Рош Аг	1, 5-нафтиридиназолидиноны, обладающие cdk1 антипролиферативной активностью
BRPI0518164A (pt) *	2004-10-14	2008-11-04	Hoffmann La Roche	quinazolinilmetilenotiazolinonas como inibidores de cdk1
WO2006040049A1 (en) *	2004-10-14	2006-04-20	F. Hoffmann-La Roche Ag	Novel azaindole thiazolinones as anti-cancer agents
US7304074B2 (en) *	2005-04-05	2007-12-04	Hoffmann-La Roche Inc.	Substituted 1,5-naphthyridine azolinones
AR053602A1 (es) *	2005-05-03	2007-05-09	Smithkline Beecham Corp	Compuesto de 2- arilamino -4-oxo-1,3-tiazol-5(4h)- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del compuesto para preparar un medicamento
US20090203692A1 (en) *	2005-05-23	2009-08-13	Smithkline Beecham Corporation	Novel chemical compounds
JP2008543769A (ja) *	2005-06-08	2008-12-04	スミスクライン・ビーチャム・コーポレイション	（５ｚ）−５−（６−キノキサリニルメチリデン）−２−［（２，４，６−トリクロロフェニル）アミノ］−１，３−チアゾール−４（５ｈ）−オン
PE20070083A1 (es) *	2005-06-08	2007-01-27	Smithkline Beecham Corp	(5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona
TW200745066A (en) *	2005-09-16	2007-12-16	Torrent Pharmaceuticals Ltd	Novel PTP1B inhibitors
EP1954136A4 (en) *	2005-11-08	2011-01-05	Glaxosmithkline Llc	NEW CHEMICAL COMPOUNDS
JP2009528383A (ja) *	2006-03-02	2009-08-06	スミスクライン・ビーチャム・コーポレイション	Ｐｉ３キナーゼ阻害剤として用いるためのチアゾロン
WO2007103758A2 (en) *	2006-03-02	2007-09-13	Smithkline Beecham Corporation	Thiazolones for use as pi3 kinase inhibitors
KR100752757B1 (ko) *	2006-04-05	2007-08-29	한국과학기술연구원	2-페닐이미노-1,3-티아졸린을 포함하는 미백 조성물
RU2008146422A (ru) *	2006-04-25	2010-05-27	Дзе Кливленд Клиник Фаундейшн (Us)	Антивирусные агенты, активирующие рибонуклеазу l
MX2009005048A (es) *	2006-11-23	2009-05-25	Actelion Pharmaceuticals Ltd	Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.
US8912340B2 (en)	2006-11-23	2014-12-16	Actelion Pharmaceuticals Ltd.	Process for the preparation of 2-imino-thiazolidin-4-one derivatives
US20100286041A1 (en) *	2007-03-22	2010-11-11	Smithkline Beecham Corporation	(5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
CN101274918A (zh) *	2007-03-30	2008-10-01	中国科学院上海药物研究所	一类取代五元杂环化合物,其制备方法和医学用途
US8119812B2 (en)	2009-04-20	2012-02-21	Sbi Biotech Co., Ltd.	Thiazolidinone derivative
CN104520303B (zh)	2012-07-30	2017-04-12	国立大学法人京都大学	关于精神神经疾病或恶性肿瘤的化合物及医药组合物
RS60408B1 (sr)	2012-08-17	2020-07-31	Actelion Pharmaceuticals Ltd	Postupak za pripremanje (2z,5z)-5-(3-hloro-4-((r)-2,3-dihidroksipropoksi)benziliden)-2-(propilimino)-3-(o-tolil)tiazolidin-4-ona i međujedinjenja upotrebljena u pomenutom postupku
RU2521390C1 (ru) *	2013-03-14	2014-06-27	Общество с ограниченной ответственностью "Тиацен"	Производное роданина и средство для профилактики опухолевых заболеваний
US10155754B2 (en) *	2014-05-28	2018-12-18	Universitat Bern	Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
CN104370852B (zh) *	2014-11-26	2016-04-20	山东大学	一种噻唑烷酮类化合物及其在制备治疗铁紊乱相关疾病药物中的应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1604530A (is)	1967-06-06	1971-11-29
JPS5545648A (en)	1978-09-29	1980-03-31	Teikoku Hormone Mfg Co Ltd	2-formyldibenzazepin derivative and its preparation
HU188852B (en) *	1983-03-16	1986-05-28	Richter Gedeon Vegyeszeti Gyar Rt,Hu	Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
SU1611216A3 (ru) *	1986-12-29	1990-11-30	Пфайзер Инк (Фирма)	Способ получени производных тиазолидиндиона или их фармацевтически приемлемых солей с щелочными металлами
US4971996A (en)	1987-03-11	1990-11-20	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors
JPH0197926A (ja)	1987-10-09	1989-04-17	Idemitsu Kosan Co Ltd	有機非線型光学材料
DD270072A1 (de)	1988-03-14	1989-07-19	Univ Halle Wittenberg	Verfahren zur herstellung von 5-aryliden- hoch 2-thiazolin-4-onen
US5306822A (en)	1988-05-25	1994-04-26	Warner-Lambert Company	Arylmethylenyl derivatives of oxazolidinone
US5145753A (en)	1989-09-12	1992-09-08	Mitsubishi Jukogyo Kabushiki Kaisha	Solid electrolyte fuel cell
US5053420A (en)	1989-10-13	1991-10-01	Pershadsingh Harrihar A	Thiazolidine derivatives for the treatment of hypertension
GB9004483D0 (en)	1990-02-28	1990-04-25	Erba Carlo Spa	New aryl-and heteroarylethenylene derivatives and process for their preparation
US5143928A (en)	1990-03-27	1992-09-01	Warner-Lambert Company	3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
JPH052200A (ja)	1990-09-28	1993-01-08	Toshiba Corp	有機非線形光学材料
WO1992013561A1 (en) *	1991-02-08	1992-08-20	Pro-Neuron, Inc.	Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
JP3155050B2 (ja)	1991-02-28	2001-04-09	富士通株式会社	荷電粒子ビームを用いた露光方法
DE69318863T2 (de)	1992-02-03	1998-09-24	Fuji Photo Film Co Ltd	Verfahren zur Dispergierung eines Farbstoffs und ein Farbstoff enthaltendes photographisches Silberhalogenidmaterial
JP2835246B2 (ja)	1992-06-02	1998-12-14	富士写真フイルム株式会社	ハロゲン化銀写真感光材料
IL106877A (en)	1992-09-10	1998-03-10	Lilly Co Eli	Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease
EP0587229B1 (en)	1992-09-11	2002-05-08	Agfa-Gevaert	Photographic element containing a filter dye for rapid processing applications
EP0587230B1 (en)	1992-09-11	2003-11-26	Agfa-Gevaert	Photographic element containing a filter dye for rapid processing applications
JPH06128234A (ja)	1992-10-19	1994-05-10	Fuji Photo Film Co Ltd	不斉炭素原子を有する化合物およびそれからなる非線形光学材料
US5554767A (en)	1993-05-21	1996-09-10	Warner-Lambert Company	Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
US6251928B1 (en)	1994-03-16	2001-06-26	Eli Lilly And Company	Treatment of alzheimer's disease employing inhibitors of cathepsin D
JP3871354B2 (ja)	1994-07-29	2007-01-24	株式会社フジモト・コーポレーション	新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体
JPH08109176A (ja)	1994-10-07	1996-04-30	Torii Yakuhin Kk	イソローダニンｎ酢酸誘導体
IL117208A0 (en)	1995-02-23	1996-06-18	Nissan Chemical Ind Ltd	Indole type thiazolidines
US5955616A (en) *	1995-07-31	1999-09-21	Shionogi & Co., Ltd.	Pyrrolidine derivatives having phospholipase A2 inhibitory activity
US5618835A (en)	1996-02-01	1997-04-08	The Procter & Gamble Company	Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
JPH09255669A (ja)	1996-03-22	1997-09-30	Hisamitsu Pharmaceut Co Inc	新規なベンジリデン誘導体
US5958957A (en)	1996-04-19	1999-09-28	Novo Nordisk A/S	Modulators of molecules with phosphotyrosine recognition units
UY24886A1 (es)	1997-02-18	2001-08-27	Smithkline Beecham Plc	Tiazolidindiona
US6011031A (en)	1997-05-30	2000-01-04	Dr. Reddy's Research Foundation	Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
US6211209B1 (en) *	1997-08-08	2001-04-03	Warner-Lambert Company	Method of inhibiting connective tissue degradation
WO1999059586A1 (en)	1998-05-19	1999-11-25	Regents Of The University Of California	Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
AU6330999A (en)	1998-09-30	2000-04-17	Roche Diagnostics Gmbh	Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US6221613B1 (en)	1998-12-31	2001-04-24	Synaptic Pharmaceutical Corporation	DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US6689491B1 (en)	1999-02-08	2004-02-10	Fuji Photo Film Co., Ltd.	Luminescent device material, luminescent device using the same, and amine compound
EP1109808A1 (en)	1999-07-01	2001-06-27	Geron Corporation	Substituted indole compounds and their use for the treatment of cancer
JP2001348520A (ja)	2000-04-03	2001-12-18	Fuji Photo Film Co Ltd	メチン化合物、固体微粒子分散物、インクジェット用記録液、およびインクジェット記録方法
EP1299362A4 (en)	2000-07-05	2004-11-03	Synaptic Pharma Corp	SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
US6410734B1 (en)	2000-07-17	2002-06-25	Wyeth	2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
DE10115227A1 (de)	2001-03-28	2002-12-19	Bayer Ag	Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren
US6452014B1 (en)	2000-12-22	2002-09-17	Geron Corporation	Telomerase inhibitors and methods of their use
AR037714A1 (es)	2001-12-06	2004-12-01	Maxia Pharmaceuticals Inc	Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer

2003
- 2003-11-18 NZ NZ539873A patent/NZ539873A/en not_active IP Right Cessation
- 2003-11-18 PL PL377564A patent/PL377564A1/pl not_active Application Discontinuation
- 2003-11-18 KR KR1020057009243A patent/KR20050085115A/ko not_active Ceased
- 2003-11-18 JP JP2004555721A patent/JP2006509765A/ja not_active Ceased
- 2003-11-18 SI SI200331463T patent/SI1567112T1/sl unknown
- 2003-11-18 AP AP2005003304A patent/AP1967A/xx active
- 2003-11-18 US US10/535,690 patent/US7767701B2/en not_active Expired - Fee Related
- 2003-11-18 CA CA002507256A patent/CA2507256A1/en not_active Abandoned
- 2003-11-18 EP EP03796448A patent/EP1567112B1/en not_active Expired - Lifetime
- 2003-11-18 CN CN200380109119A patent/CN100579978C/zh not_active Expired - Fee Related
- 2003-11-18 DK DK03796448T patent/DK1567112T3/da active
- 2003-11-18 AT AT03796448T patent/ATE411302T1/de active
- 2003-11-18 MX MXPA05005406A patent/MXPA05005406A/es active IP Right Grant
- 2003-11-18 EA EA200500856A patent/EA008865B1/ru not_active IP Right Cessation
- 2003-11-18 ES ES03796448T patent/ES2315566T3/es not_active Expired - Lifetime
- 2003-11-18 DE DE60324178T patent/DE60324178D1/de not_active Expired - Lifetime
- 2003-11-18 PT PT03796448T patent/PT1567112E/pt unknown
- 2003-11-18 AU AU2003298693A patent/AU2003298693B2/en not_active Ceased
- 2003-11-18 UA UAA200504788A patent/UA80572C2/uk unknown
- 2003-11-18 WO PCT/US2003/037658 patent/WO2004047760A2/en not_active Ceased
- 2003-11-18 BR BR0316502-7A patent/BR0316502A/pt not_active IP Right Cessation
- 2003-11-18 OA OA1200500154A patent/OA12963A/en unknown
- 2003-11-20 AR ARP030104299A patent/AR045407A1/es not_active Application Discontinuation
- 2003-11-20 TW TW092132476A patent/TWI309648B/zh not_active IP Right Cessation
- 2003-11-20 MY MYPI20034473A patent/MY140132A/en unknown
2005
- 2005-05-20 EC EC2005005808A patent/ECSP055808A/es unknown
- 2005-05-27 MA MA28303A patent/MA27701A1/fr unknown
- 2005-06-02 IS IS7879A patent/IS2659B/is unknown
- 2005-06-15 NO NO20052928A patent/NO20052928L/no not_active Application Discontinuation
2008
- 2008-12-29 CY CY20081101499T patent/CY1108655T1/el unknown

Also Published As

Publication number	Publication date
SI1567112T1 (sl)	2009-02-28
AU2003298693B2 (en)	2010-09-30
CA2507256A1 (en)	2004-06-10
EA008865B1 (ru)	2007-08-31
DE60324178D1 (de)	2008-11-27
EP1567112B1 (en)	2008-10-15
MA27701A1 (fr)	2006-01-02
EA200500856A1 (ru)	2005-10-27
AU2003298693A1 (en)	2004-06-18
ECSP055808A (es)	2005-09-20
ES2315566T3 (es)	2009-04-01
MY140132A (en)	2009-11-30
PL377564A1 (pl)	2006-02-06
ATE411302T1 (de)	2008-10-15
US20060293338A1 (en)	2006-12-28
CN100579978C (zh)	2010-01-13
EP1567112A2 (en)	2005-08-31
WO2004047760A3 (en)	2004-10-21
BR0316502A (pt)	2005-10-04
AP1967A (en)	2009-03-10
TWI309648B (en)	2009-05-11
HK1083443A1 (en)	2006-07-07
AP2005003304A0 (en)	2005-06-30
JP2006509765A (ja)	2006-03-23
UA80572C2 (en)	2007-10-10
AR045407A1 (es)	2005-10-26
KR20050085115A (ko)	2005-08-29
NZ539873A (en)	2008-09-26
MXPA05005406A (es)	2005-08-03
US7767701B2 (en)	2010-08-03
PT1567112E (pt)	2009-01-08
CY1108655T1 (el)	2014-04-09
CN1742010A (zh)	2006-03-01
IS2659B (is)	2010-08-15
WO2004047760A2 (en)	2004-06-10
EP1567112A4 (en)	2006-11-15
TW200418819A (en)	2004-10-01
DK1567112T3 (da)	2009-02-09
OA12963A (en)	2006-10-13
NO20052928L (no)	2005-08-17
NO20052928D0 (no)	2005-06-15

Publication	Publication Date	Title
IS7471A (is)	2004-10-15	Ný efnasambönd
IS7879A (is)	2005-06-02	Ný efnasambönd
ATE368042T1 (de)	2007-08-15	Cephemverbindungen
IS8108A (is)	2005-10-31	Ný efnasambönd
DK1605897T3 (da)	2012-08-20	Polyethelen-glycol-link-glp-1-forbindelser
IS7381A (is)	2004-08-03	Efnasambönd
NO20044046L (no)	2004-11-15	Substituerte hydroksyetylaminer
IS7414A (is)	2004-08-19	Oxó-azabísýklísk efnasambönd
IS8228A (is)	2006-01-11	Ný asetídínefnasambönd
NO20045659L (no)	2004-12-27	Forbindelser
IS7793A (is)	2005-04-11	Nýtt efnasamband
IS7827A (is)	2005-04-27	Ný efnasambönd
IS7794A (is)	2005-04-11	Nýtt efnasamband
ATE496887T1 (de)	2011-02-15	Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
IS8089A (is)	2005-10-25	Efnasambönd
IS8292A (is)	2006-02-09	Ný efnasambönd
NO20031736D0 (no)	2003-04-15	Forbindelser
ITMI20021327A1 (it)	2003-12-15	Nuove ossialchilpiperazine
SE0303452D0 (sv)	2003-12-18	New compounds
ITMI20021329A1 (it)	2003-12-15	Nuove ossialchilammine sostituite
ATE350379T1 (de)	2007-01-15	Substituierte benzdioxepine
SE0203348D0 (sv)	2002-11-12	Novel compounds
SE0202181D0 (sv)	2002-07-11	New compounds
SE0203122D0 (sv)	2002-10-22	New Compounds
SE0202908D0 (sv)	2002-10-01	New compounds